MainStreet Investment Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
MainStreet Investment Advisors's BIIB Position: Q3 2021 in Review
MainStreet Investment Advisors sold out of Biogen (BIIB) in Q3 2021, closing a stake of 14,172 shares — an estimated $4.91M sold.
MainStreet Investment Advisors first reported a position in BIIB in Q4 2017 and held it in 15 quarters. The position peaked at $5.59M in Q3 2020. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.
- MainStreet Investment Advisors reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
- MainStreet Investment Advisors sold 14,172 Biogen shares in Q3 2021, an estimated $4.91M.
- MainStreet Investment Advisors first reported a position in Biogen in Q4 2017 and held it in 15 quarters.
- MainStreet Investment Advisors's Biogen position peaked at $5.59M in Q3 2020.
- 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.
Based on MainStreet Investment Advisors's 13F filing for Q3 2021, filed 8 Nov 2021.